Interface Biologics' Incubator/Accelerator Round

Interface Biologics raised a round of funding on December 06, 2011. Investors include MaRS Investment Accelerator Fund.

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI's primary te…

Articles about Interface Biologics' Incubator/Accelerator Round: